Autologous Transplantation for Parkinson's Disease Patients: Feasibility and Challenge.
作者信息
Zhang Qi, Wang Yanlin, Wang Yukai, Liu Han, Sun Huifang, Wang Zhuoya, Shi Changhe, Yang Jing, Xu Yuming
机构信息
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Academy of Medical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
出版信息
Neurosci Bull. 2021 Jul;37(7):1085-1086. doi: 10.1007/s12264-021-00712-w. Epub 2021 May 27.
Abstract
摘要
相似文献
1
Autologous Transplantation for Parkinson's Disease Patients: Feasibility and Challenge.
Neurosci Bull. 2021 Jul;37(7):1085-1086. doi: 10.1007/s12264-021-00712-w. Epub 2021 May 27.
2
Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases.
Stereotact Funct Neurosurg. 1997;69(1-4 Pt 2):112-5. doi: 10.1159/000099860.
3
Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease.
Transl Res. 2010 Feb;155(2):62-70. doi: 10.1016/j.trsl.2009.07.006. Epub 2009 Aug 6.
4
Adrenal medulla autografts in Parkinson's disease: a proposed mechanism of action.
Can J Neurol Sci. 1988 Nov;15(4):366-70.
5
Auto transplants for Parkinson's disease?
Neuron. 1998 Feb;20(2):169-72. doi: 10.1016/s0896-6273(00)80445-6.
6
Autologous adrenal medulla to caudate nucleus transplantation in advanced Parkinson's disease: 18 month results.
Prog Brain Res. 1990;82:637-42. doi: 10.1016/s0079-6123(08)62654-0.
7
Transplantation of autologous cervical sympathetic ganglion into the brain with Parkinson's disease: experimental and clinical studies.
Cell Transplant. 1994;3 Suppl 1:S43-5. doi: 10.1177/096368979400301s16.
8
Adrenal medullary autografts in patients with Parkinson's disease.
N Engl J Med. 1989 Aug 3;321(5):324-7. doi: 10.1056/NEJM198908033210512.
9
Parkinson's disease--a new therapy?
N Engl J Med. 1987 Apr 2;316(14):872-3. doi: 10.1056/NEJM198704023161410.
10
[Intracerebral grafts in Parkinson's disease, a great bustle].
Rev Prat. 1989 Jan 19;39(1):43-4.
本文引用的文献
1
Balancing Expectations for Success in Stem Cell-Based Clinical Trials for Parkinson's Disease.
Cell Stem Cell. 2020 Oct 1;27(4):519-522. doi: 10.1016/j.stem.2020.09.002.
2
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.
N Engl J Med. 2020 May 14;382(20):1926-1932. doi: 10.1056/NEJMoa1915872.
3
Diagnosis and Treatment of Parkinson Disease: A Review.
JAMA. 2020 Feb 11;323(6):548-560. doi: 10.1001/jama.2019.22360.
4
Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.
J Clin Invest. 2020 Feb 3;130(2):904-920. doi: 10.1172/JCI130767.
5
Biomarkers for Parkinson's Disease: How Good Are They?
Neurosci Bull. 2020 Feb;36(2):183-194. doi: 10.1007/s12264-019-00433-1. Epub 2019 Oct 23.
6
Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.
Neurosci Bull. 2019 Dec;35(6):1085-1096. doi: 10.1007/s12264-019-00407-3. Epub 2019 Jul 8.
7
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.
8
Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.
Nature. 2017 Aug 30;548(7669):592-596. doi: 10.1038/nature23664.
9
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
Nature. 2011 Nov 6;480(7378):547-51. doi: 10.1038/nature10648.
10
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell. 2007 Nov 30;131(5):861-72. doi: 10.1016/j.cell.2007.11.019.
Zotero 插件